Senators Max Baucus (D-Mont.) and Ted Kennedy (D-Mass.) have set a
timetable for healthcare reform by this fall – a major step on the road
to passing legislation this year. The Senators’ plan, set out in a
letter to President Obama, calls for a bill by June, committee markups
over the summer, and a final vote in the fall. (Just in time for
delayed-action budget reconciliation, should the Republicans prove
As Steve Benen of the Washington Monthly notes, timetables matter, politically. Furthermore, as Ezra Klein explains at TAPPED, a pact between Baucus and Kennedy is a big step forward: these two key committee chairs now have a plan to avoid the turf wars
that stymied reform in 1994. This time, the two Senators have pledged
to work together to write similar bills, instead having their
respective committees produce very different legislation, like they did
Experts agree that successful healthcare reform must work on two
fronts: Paying for care while simultaneously keeping the cost of care
in check. Elsewhere on TAPPED, Klein discusses why American healthcare costs so much
compared to other countries. He points to a study by the famous
McKinsey consulting company showing that the extra cost is not because
we’re sicker, nor because we consume more healthcare:
The answer, in the end, is that we’re
getting a bad deal. You know how when you go shopping you look for
sales? America sort of does the opposite of that. We pay more for each
unit of care, more for health system operations, and more for health
system administration. McKinsey found that "input costs-including
doctors’ and nurses’ salaries, drugs, devices, and other medical
supplies, and the proﬁts of private participants in the system-explain
the largest portion of high additional spending, accounting for $281
billion of spending above US [Estimated Spending According to Wealth].
Inefﬁciencies and complexity in the system’s operational processes and
structure account for the second largest spend above ESAW of $147
billion. Finally, administration, regulation, and intermediation of the
system cost another $98 billion in additional spending."
Appreciate our work?
Vote now! And help Rewire earn a bigger grant from CREDO:
Marcia Greenberger of the National Women’s Law Center outlines what’s at stake for women in the healthcare reform debate at Rewire. She writes:
In our broken health care system,
nearly one in five women is uninsured. Even for those who have health
insurance, women are more likely than men to have health coverage that
has too many gaps, including large co-pays, life-time limits, and
exclusions or limitations in needed services like mental health care or
prescription drugs. Since women, on average, have lower incomes than
men, they are at particular risk of financial barriers to care; one in
four women says that she is unable to pay her medical bills, and women
are more likely than men to delay or go without needed health care
because of cost.
Speaking of raw deals, Martha Rosenberg describes how big pharma distorts science to get approval for yet more drugs of questionable safety and efficacy in AlterNet.
Rosenberg notes that the Justice Department is cracking down on
AstraZeneca and Forest Laboratories for hiding key scientific evidence
that called the safety of their products into question.
What pharmaceutical companies aren’t dumping onto the market, they’re dumping into the water supply,
according Lauren Kirchner of Air America Radio: 271 million pounds of
drugs, from antibiotics to tranquilizers, have been legally dumped into
the U.S. water supply over the past 20 years.
The Vatican keeps nixing Barack Obama’s picks for ambassador to Vatican City
for being pro-choice, according to the American Forum. Carolyn Kennedy
was a front-runner until she was disqualified for being personally
pro-choice. I would note that there’s something of a Catch-22 here.
Minor ambassadorships are, after all, rewards for big time political
backers. The only reason anyone is in line for this job is because they
helped the pro-choice Barack Obama get elected. This could take a while.